Skip to content
Dynamic Cards Lounge

Patients Stopping Weight-Loss Injections Put On Weight at a Quadrupled Rate Than People Using Diet and Exercise

Illustration of medical injection and scale
Weight management often requires long-term strategies.

Fresh analysis indicates that people who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain lost weight far faster than those who end conventional lifestyle regimens.

Research printed in a prominent health publication demonstrates that while overweight people can lose a large proportion of their total mass while undergoing treatment, the weight returns at an average rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such treatments must be informed of the potential of quick weight regain when the therapy ends," stated expert Dr. Susan Jebb.

That rate of regain implies a return to starting weight in about a year and a half.

Analyzing Approaches

The analysis, which looked at dozens of studies involving thousands of patients, contrasted the effects of these new drugs with other pills.

The team point out that people who lose weight through diet and exercise typically have a slower weight regain—approximately 0.1 kg a month—post-intervention.

Explaining the Quick Regain

Doctors believe the way of the drugs accounts for the heightened regain.

These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Artificially providing the hormone concentrations several times higher than normal might result in the body to produce less of its own natural hormone, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Stopping of this hormone supplement means appetite is uncontrolled, making excessive eating much more probable."

A Chronic Disease?

Medical guidelines advise the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.

Professionals argue that, considering the high risk of relapse, the therapy might need to be long-term.

This view is supported by drug manufacturers, who say that the results "highlight the chronic character of excess weight," comparing it to managing diseases like diabetes.

User Accounts

People who have stopped the medication report a powerful return of hunger.

"It was like a trigger flipping and you're instantly starving," said a patient.

This challenge is exacerbated if users have not established permanent dietary or behavioural changes during therapy.

Significant Interest

Figures show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.

  • Use is greater among women compared to males.
  • The 40s and 50s age group shows the greatest usage rates.
  • Many obtain the drugs through private prescriptions rather than the NHS.

Ultimately, researchers caution that while the jabs are powerful agents for shedding pounds, they are not a magic fix and lasting health benefits relies on ongoing behavioural management.

About the author

Robert Young

A graphic designer with over a decade of experience specializing in custom card designs and digital art techniques.

Dynamic Cards Lounge

Type to search articles.